Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine for Antipsychotic-Induced Weight Gain
NCT00709202Phase 2Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Jul 2008
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of betahistine in antipsychotic-induced weight gain (AIWG), sponsored by Nathan S. Kline Institute for Psychiatric Research. Started Jul 2008; status: completed.
02
Drugs
betahistine
03
Conditions
antipsychotic-induced weight gain (AIWG)
Beyond the preview
Go deeper on NCT00709202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709202.